학술논문
Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer
Document Type
Article
Author
Source
In Clinical Breast Cancer February 2016 16(1):31-37
Subject
Language
ISSN
1526-8209